Asembia Relocates To Larger Corporate Headquarters In Florham Park, New Jersey
06/15/2016
According to company officials, “these larger offices will help support the growth in personnel required to further develop the company's data analytics and technology offerings, pharmaceutical group purchasing portfolio, patient-centric hub support services and other related products. “
"This move is more than just an expansion of our office space," said Robert J. Irene, president and co-founder of Asembia. "These larger offices will allow us to increase the current staff in each of our departments as we continue to develop innovative products and solutions for the rapidly evolving specialty pharmacy industry." Irene continued, "Our entire business model focuses on collaborating with our pharmacy customers and industry partners to deliver proven solutions that help support the growth of the specialty pharmacy industry."
“The move follows a recent company name change and brand awareness campaign,” a company spokesperson said. “Asembia is a nationally recognized leader in developing unique manufacturer programs and solutions for specialty pharmaceuticals. These offerings deliver value propositions to member pharmacies, pharmaceutical manufacturer partners, national payers and other related healthcare industry stakeholders."
Project Announcements
Australia-Based Aquatic Leisure Technologies Group Plans Opp, Alabama, Manufacturing Operations
12/11/2025
Teradyne Plans Wixom, Michigan, Robotics Operations
12/11/2025
Robinson Plans Altoona, Iowa, Manufacturing Operations
12/11/2025
BioTouch Expands Columbus, Georgia, Operations
12/11/2025
Natrion Plans Erie County, New York, Battery Components Operations
12/11/2025
Czech-Based GZ PrintPak Expands Mount Pleasant, Wisconsin, Manufacturing Operations
12/11/2025
Most Read
-
The Workforce Bottleneck in America’s Manufacturing Revival
Q4 2025
-
Rethinking Local Governments Through Consolidation and Choice
Q3 2025
-
Lead with Facts, Land the Deal
Q3 2025
-
How Canada Stays Competitive
Q3 2025
-
Investors Seek Shelter in Food-Focused Real Estate
Q3 2025
-
America’s Aerospace Reboot
Q3 2025
-
The Permit Puzzle and the Path to Groundbreaking
Q3 2025